IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Igene Biotechnology Inc (IGNE)

Q2 2019 vs Q3 2019

Comparing institutional holders between quarters

Quarters

Q3 2019Q2 2019Q1 2019Q4 2018Q3 2018
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Kimelman & Baird, LLC
UNCHANGED
Shares7,390,923 from 7,390,923
Change0 (0%)
Value$3 (+$1)
Filed 2019-12-10
Status
Kimelman & Baird, LLC
UNCHANGED7,390,9237,390,92300%$2$3+$12019-12-10
Showing 1 of 1 institutions